R.C.C - Reliance Contracting Co.

R.C.C - Reliance Contracting Co. company information, Employees & Contact Information

Reliance Contracting Company - R.C.C is Specialized in M.E.P industry for onshore and offshore projects, well known by high qualified consultants, customers and contractors all over the U.A.E as one of the best professional managed co. "Our aim is to achieve the business excellence by providing the highest quality services in M.E.P industry"
Looking for a particular R.C.C - Reliance Contracting Co. employee's phone or email?

R.c.c - Reliance Contracting Co. Questions

News

George Shares Takeaways From IO Trials and AE Management in Pretreated RCC - Targeted Oncology

George Shares Takeaways From IO Trials and AE Management in Pretreated RCC Targeted Oncology

RCC Resale Shop opens in Texas City - Community Impact | News

RCC Resale Shop opens in Texas City Community Impact | News

KIM-1 Represents a Potential Biomarker for Outcomes and Response in RCC - OncLive

KIM-1 Represents a Potential Biomarker for Outcomes and Response in RCC OncLive

Zanzalintinib plus nivolumab shows safety, efficacy for stage 4 RCC - Urology Times

Zanzalintinib plus nivolumab shows safety, efficacy for stage 4 RCC Urology Times

Cabozantinib Combo Yields Sustained PFS at Follow-Up in Advanced RCC - CancerNetwork

Cabozantinib Combo Yields Sustained PFS at Follow-Up in Advanced RCC CancerNetwork

2025 Regional Club Championships - USA Field Hockey

2025 Regional Club Championships USA Field Hockey

Investigators characterize safety profile of belzutifan in advanced RCC - Urology Times

Investigators characterize safety profile of belzutifan in advanced RCC Urology Times

ESMO 2024: Non-Clear Cell RCC - UroToday

ESMO 2024: Non-Clear Cell RCC UroToday

RCC Students Shine at National Cybersecurity Competitions - Rensselaer Polytechnic Institute (RPI)

RCC Students Shine at National Cybersecurity Competitions Rensselaer Polytechnic Institute (RPI)

RCC’s first ‘Hackathon’ called a winner for all who competed - Dorchester Reporter |

RCC’s first ‘Hackathon’ called a winner for all who competed Dorchester Reporter |

Fotivda Monotherapy Demonstrated Efficacy in Previously Treated Metastatic RCC - Cure Today

Fotivda Monotherapy Demonstrated Efficacy in Previously Treated Metastatic RCC Cure Today

Incentivizing RCC Research Investment Across Lower-Income Countries - CancerNetwork

Incentivizing RCC Research Investment Across Lower-Income Countries CancerNetwork

RCC Monthly Rewind: Key News and Expert Insights You May Have Missed in September 2025 - OncLive

RCC Monthly Rewind: Key News and Expert Insights You May Have Missed in September 2025 OncLive

Evaluating Efficacy of Second-Line RCC Treatments Post-Immunotherapy - Targeted Oncology

Evaluating Efficacy of Second-Line RCC Treatments Post-Immunotherapy Targeted Oncology

Machine Learning Approach May Predict Outcomes in RCC - CancerNetwork

Machine Learning Approach May Predict Outcomes in RCC CancerNetwork

Mar Reviews First-Line Therapy in Metastatic Non-Clear Cell RCC - Targeted Oncology

Mar Reviews First-Line Therapy in Metastatic Non-Clear Cell RCC Targeted Oncology

Pembrolizumab/Lenvatinib Combination Produces Durable Responses in Advanced Non–Clear Cell RCC - OncLive

Pembrolizumab/Lenvatinib Combination Produces Durable Responses in Advanced Non–Clear Cell RCC OncLive

What's Next for Frontline Metastatic RCC Therapy - Targeted Oncology

What's Next for Frontline Metastatic RCC Therapy Targeted Oncology

Ornstein Discusses TKI Dose Interruption and Discontinuation in Combination RCC Therapy - Targeted Oncology

Ornstein Discusses TKI Dose Interruption and Discontinuation in Combination RCC Therapy Targeted Oncology

AUA 2024: Risk Stratification for Adjuvant Therapy with High Risk RCC - UroToday

AUA 2024: Risk Stratification for Adjuvant Therapy with High Risk RCC UroToday

Pembrolizumab Extends Survival in RCC: 5-Year Study Results - Targeted Oncology

Pembrolizumab Extends Survival in RCC: 5-Year Study Results Targeted Oncology

SABR Leads to Local Control in Primary RCC Without Surgery - OncLive

SABR Leads to Local Control in Primary RCC Without Surgery OncLive

Q&A – Advanced RCC: A Potential New Treatment Target - Medscape

Q&A – Advanced RCC: A Potential New Treatment Target Medscape

New Data Bring Excitement, Raise Questions in Advanced RCC - OncLive

New Data Bring Excitement, Raise Questions in Advanced RCC OncLive

Novel Therapeutic Targets Represent Unmet Need in Translocation RCC - Targeted Oncology

Novel Therapeutic Targets Represent Unmet Need in Translocation RCC Targeted Oncology

Nuclear Speckle Signatures in Clear Cell RCC - The ASCO Post

Nuclear Speckle Signatures in Clear Cell RCC The ASCO Post

Radiotherapy Defers Systemic Therapy in Oligometastatic RCC - Medscape

Radiotherapy Defers Systemic Therapy in Oligometastatic RCC Medscape

Ornstein Advises on Starting Dose and Management of Lenvatinib in RCC - Targeted Oncology

Ornstein Advises on Starting Dose and Management of Lenvatinib in RCC Targeted Oncology

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu - Oncodaily

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu Oncodaily

Salvage Nivolumab/Ipilimumab Following Nivolumab Affords Treatment-Free Survival in RCC - OncLive

Salvage Nivolumab/Ipilimumab Following Nivolumab Affords Treatment-Free Survival in RCC OncLive

From Bench to Bedside: HIF-2α Inhibition in RCC - OncLive

From Bench to Bedside: HIF-2α Inhibition in RCC OncLive

Tolerability Concerns Influence Use of Lenvatinib/Everolimus Vs Tivozanib in RCC - Targeted Oncology

Tolerability Concerns Influence Use of Lenvatinib/Everolimus Vs Tivozanib in RCC Targeted Oncology

Exciting New Treatment Updates Are on the Horizon for Advanced RCC - CancerNetwork

Exciting New Treatment Updates Are on the Horizon for Advanced RCC CancerNetwork

RCC-Supporter: supporting renal cell carcinoma treatment decision-making using machine learning - BMC Medical Informatics and Decision Making

RCC-Supporter: supporting renal cell carcinoma treatment decision-making using machine learning BMC Medical Informatics and Decision Making

Belzutifan Shows Manageable, Pooled Safety Profile in Advanced VHL-Associated RCC - OncLive

Belzutifan Shows Manageable, Pooled Safety Profile in Advanced VHL-Associated RCC OncLive

Regional Cyber Center - CONUS designated elite and Army’s 2024 RCC of the Year - army.mil

Regional Cyber Center - CONUS designated elite and Army’s 2024 RCC of the Year army.mil

Clear Cell RCC: Strategies for Selecting Appropriate Frontline Treatment - Targeted Oncology

Clear Cell RCC: Strategies for Selecting Appropriate Frontline Treatment Targeted Oncology

The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs - BMC Cancer

The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs BMC Cancer

Rationale Behind Discontinuing IO Therapy in Clear Cell RCC - OncLive

Rationale Behind Discontinuing IO Therapy in Clear Cell RCC OncLive

CDAO Official: AI RCC Keeps DoD at Pace With Industry Innovation - MeriTalk

CDAO Official: AI RCC Keeps DoD at Pace With Industry Innovation MeriTalk

Using Clinical Characteristics to Guide Treatment of Recurrent RCC After Adjuvant Pembrolizumab - ASCO Daily News

Using Clinical Characteristics to Guide Treatment of Recurrent RCC After Adjuvant Pembrolizumab ASCO Daily News

Benmelstobart Plus Anlotinib Demonstrates Efficacy in Frontline Advanced RCC - OncLive

Benmelstobart Plus Anlotinib Demonstrates Efficacy in Frontline Advanced RCC OncLive

89Zr-DFO-girentuximab Showcases Sensitivity, Specificity for Clear Cell RCC Imaging - OncLive

89Zr-DFO-girentuximab Showcases Sensitivity, Specificity for Clear Cell RCC Imaging OncLive

Adjuvant Pembrolizumab Improves OS in Select Patients With RCC After Nephrectomy - OncLive

Adjuvant Pembrolizumab Improves OS in Select Patients With RCC After Nephrectomy OncLive

RCC Histologies: Clear Cell vs Non–Clear Cell - Targeted Oncology

RCC Histologies: Clear Cell vs Non–Clear Cell Targeted Oncology

Targeting glutamine use in RCC - Nature

Targeting glutamine use in RCC Nature

ctDNA May Guide Treatment Intensity in RCC - Targeted Oncology

ctDNA May Guide Treatment Intensity in RCC Targeted Oncology

Zakharia Evaluates Available Combination Options for Non–Clear Cell RCC - Targeted Oncology

Zakharia Evaluates Available Combination Options for Non–Clear Cell RCC Targeted Oncology

Second-Line Considerations After Immune Toxicity From Prior RCC Therapy - Targeted Oncology

Second-Line Considerations After Immune Toxicity From Prior RCC Therapy Targeted Oncology

RCC - Regulatory Affairs Professionals Society | RAPS

RCC Regulatory Affairs Professionals Society | RAPS

HIF-2α Inhibitor Monotherapy Shows Preliminary Activity, Safety in RCC - Targeted Oncology

HIF-2α Inhibitor Monotherapy Shows Preliminary Activity, Safety in RCC Targeted Oncology

Cabozantinib After CPI-Based Combination Therapy Showcases Early Efficacy in Advanced RCC - OncLive

Cabozantinib After CPI-Based Combination Therapy Showcases Early Efficacy in Advanced RCC OncLive

Regional Cyber Center-Pacific is NETCOM’s RCC of the Year - army.mil

Regional Cyber Center-Pacific is NETCOM’s RCC of the Year army.mil

Atezolizumab/Bevacizumab Demonstrates Comparable OS to Sunitinib for Metastatic RCC - CancerNetwork

Atezolizumab/Bevacizumab Demonstrates Comparable OS to Sunitinib for Metastatic RCC CancerNetwork

Earthshot Prize Names RCC Kampala Official Nominator - UNFCCC

Earthshot Prize Names RCC Kampala Official Nominator UNFCCC

With Nivolumab/Ipilimumab, Advanced RCC Survival Approaches 5 Years - Targeted Oncology

With Nivolumab/Ipilimumab, Advanced RCC Survival Approaches 5 Years Targeted Oncology

Choosing Appropriate Patients and Dosing for Lenvatinib + Pembrolizumab in RCC - CancerNetwork

Choosing Appropriate Patients and Dosing for Lenvatinib + Pembrolizumab in RCC CancerNetwork

Choosing Among First-Line IO/TKI Combos in RCC: The Affordable Option Is the Winner - OncLive

Choosing Among First-Line IO/TKI Combos in RCC: The Affordable Option Is the Winner OncLive

With NIVO + IPI, Advanced RCC Survival Approaches 5 years - Targeted Oncology

With NIVO + IPI, Advanced RCC Survival Approaches 5 years Targeted Oncology

How to choose systemic therapy for metastatic RCC - Urology Times

How to choose systemic therapy for metastatic RCC Urology Times

Cadex Acquires Receivables Control Corporation (RCC) - Business Wire

Cadex Acquires Receivables Control Corporation (RCC) Business Wire

A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases - The Lancet

A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases The Lancet

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC - Frontiers

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC Frontiers

RCC Headquarters - Foster + Partners

RCC Headquarters Foster + Partners

Avoid Blood Transfusions in RCC Surgery? - MedPage Today

Avoid Blood Transfusions in RCC Surgery? MedPage Today

Top R.C.C - Reliance Contracting Co. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant